United States · FDA National Drug Code directory
Glipizide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-4124_3be17f13-1bc5-11f9-e063-6394a90aa4b9
- Product NDC
- 68071-4124
- Form
- TABLET
- Composition / generic term
- Glipizide
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19950227
- Source listing expiry
- 20261231
Source-listed ingredients
- GLIPIZIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (68071-4124-2) · 68071-4124-2
- 30 TABLET in 1 BOTTLE (68071-4124-3) · 68071-4124-3
- 60 TABLET in 1 BOTTLE (68071-4124-6) · 68071-4124-6
- 180 TABLET in 1 BOTTLE (68071-4124-8) · 68071-4124-8
- 90 TABLET in 1 BOTTLE (68071-4124-9) · 68071-4124-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →